The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry

Journal of Cardiac Failure

Volumn 10, Issue 2, 2004, Pages 149-154

  Witte, Klaus K A ^a   Morice, Alyn ^a   Cleland, John G F ^a   Clark, Andrew L ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

airways resistance; breathlessness; Chronic heart failure; reversibility

Indexed keywords

BRONCHODILATING AGENT; CARBON DIOXIDE; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; AGED; AIRWAY RESISTANCE; ARTICLE; BREATHING; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPNEA; EXERCISE TEST; GAS EXCHANGE; HEART FAILURE; HUMAN; LUNG COMPLIANCE; NEBULIZER; OSCILLOMETRY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TIDAL VOLUME;

AGED; AIRWAY RESISTANCE; ALBUTEROL; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; DYSPNEA; EXERCISE TEST; HEART FAILURE, CONGESTIVE; HUMANS; IPRATROPIUM; OSCILLOMETRY; RESPIRATORY FUNCTION TESTS;

EID: 3042828461     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardfail.2003.08.007     Document Type: Article

References (33)

1. Clark A.L., Sparrow J.L., Coats A.J.S. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J. 16:1995;49-52
2. Clark A.L., Poole-Wilson P.A., Coats A.J.S. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol. 28:1996;1092-1102
3. Sullivan M.J., Higginbotham M.B., Cobb F.R. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite haemodynamic and pulmonary abnormalities. Circulation. 77:1988;552-559
4. Wasserman K., Zhang Y.-Y., Gitt A., Belardinelli R., Koike A., Lubarsky L., et al. Lung function and exercise gas exchange in chronic heart failure. Circulation. 96:1997;2221-2227
5. Kraemer M.D., Kubo S.H., Rector T.S., Brunsvold N., Bank A.J. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol. 21:1993;641-648
6. Witte K.K.A., Morice A., Clark A.L., Cleland J.G.F. Airways resistance in chronic heart failure measured by impulse oscillometry. J Cardiac Failure. 8:2002;225-231
7. Cabanes L.R., Weber S.N., Matran R., Regnard J., Richard M.O., Degeorges M.E., et al. Bronchial hyperresponsiveness to methacholine in patients with impaired left ventricular function. N Engl J Med. 320:1989;1317-1322
8. Chua T.P., Lalloo U.G., Worsdell M.Y., Kharitonov S., Chung K.F., Coats A.J.S. Airway and cough responsiveness and exhaled nitric oxide in non-smoking patients with stable chronic heart failure. Heart. 76:1996;144-149
9. McParland C., Krishnan B., Wang Y., Gallagher C.G. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis. 146:1992;467-472
10. Kindman L.A., Vagelos R.H., Willson K., Prikazky L., Fowler M. Abnormalities of pulmonary function in patients with congestive heart failure, and reversal with ipratropium bromide. Am J Cardiol. 73:1994;258-262
11. Uren N.G., Davies S.W., Jordan S.L., Lipkin D.P. Inhaled bronchodilators increase maximum oxygen consumption in chronic left ventricular failure. Eur Heart J. 14:1993;744-750
12. Moore D.P., Weston A., Hughes J.M.B., Oakley C.M., Cleland J.G.F. Bronchial hyperresponsiveness in heart failure. N Engl J Med. 328:1993;1424-1425
13. Harrington D., Chua T.P., Coats A.J. The effect of salbutamol on skeletal muscle in chronic heart failure. Int J Cardiol. 73:2000;257-265
14. Brochard L., Pelle G., de Palmas J., Brochard P., Carre A., Lorino H., et al. Density and frequency dependance of resistance in early airway obstruction. Am Rev Respir Dis. 135:1987;579-584
15. Lechtenbörger P, Lechtenbörger S, Smith H, Steinkamp G, Berdel D. Resistance and reactance measured by impulse oscillometry: paediatric reference values in 614 healthy children and adolescents aged 5 to 17 years. In press.
16. Duiverman E.J., Clement J., van de Woestijne K.P., Neijens H.J., van den Bergh A.C., Kerrebijn K.F. Forced oscillation technique. Reference values for resistance and reactance over a frequency spectrum of 2-26 Hz in healthy children aged 2.3-12.5 years. Bull Eur Physiopathol Respir. 21:1985;171-178
17. Hellinckx J., Cauberghs M., De Boeck K., Demedts M. Evaluation of impulse oscillometry system: comparison with forced oscillation technique and body plethysmography. Eur Resp J. 18:2001;564-570
18. Steinbrugger B, Weinhandl E, Zach M, Vogel J, Nolte D, Schmidt U. Workshop Impuls-Oszillometrie Bad Reichenhall 1995. Munchen-Deisenhofen: Dustri Verlag Dr Karl Feistle; 1995; Implusoszillometrie bei jugendlichen Patienten mit Musoviszidose. P130-4.
19. Aronsson H., Solymar L., Dempsey J., Bjure J., Olsson T., Bake B. A modified forced oscillation technique for measurements of respiratory resistance. J Appl Physiol. 42:1977;650-655
20. Michaelson E.D., Grassman E.D., Peters W.R. Pulmonary mechanics by spectral analysis of forced random noise. J Clin Invest. 56:1975;1210-1230
21. Làndsér F.J., Nagels J., Demedts M., Billiet L., van de Woestijne K.P. A new method to determine frequency characteristics of the respiratory system. J Appl Physiol. 41:1976;101-106
22. Chan C.S., Brown I.G., Kelly C.A., Dent A.G., Zimmerman P.V. Bronchodilator responses to nebulised ipratropium and salbutamol singly and in combination in chronic bronchitis. Br J Clin Pharmacol. 17:1984;103-105
23. Pakes G.E., Brogden R.N., Heel R.C., Speight T.M., Avery G.S. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs. 20:1980;237-266
24. Borg G. Subjective effort and physical activities. Scand J Rehab. 6:1978;108-113
25. Schmekel B., Smith H.-J. The diagnostic capacity of forced oscillation and forced expiration techniques in identifying asthma by isocapnic hyperpnoea of cold air. Eur Resp J. 10:1997;2243-2249
26. Orehek J., Nicoli M.M., Delpierre S., Beaupré A. Influence of the previous deep inspiration on the spirometric measurement of provoked bronchoconstriction in asthma. Am Rev Respir Dis. 123:1981;269-272
27. Hughes P.D., Polkey M.I., Harrus M.L., Coats A.J., Moxham J., Green M. Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med. 160:1999;529-534
28. Umut S., Gemicioglu B., Yildirim M., Barlas A., Ozuner Z. Effect of theophylline in chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther Toxicol. 30:1992;149-152
29. Ballester E., Reyes A., Roca J., Guitart R., Wagner P.D., Rodriguez-Rosin R. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax I. 44:1989;258-267
30. Wong C.S., Pavord I.D., Williams J., Britton J.R., Tatterfield A.E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 336:1990;1396-1399
31. Szidon J.P. Pathophysiology of the congested lung. Cardiol Clin. 7:1989;39-48
32. Sobol S.M., Rakita L. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug. Circulation. 65:1982;819-824
33. Wright R.S., Levine M.S., Bellamy P.E., Simmons M.S., Batra P., Stevenson L.W., et al. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest. 98:1990;816-820